| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.77▲ | 8.83▼ | 8.90▼ | 9.01▼ | 9.21▼ |
| MA10 | 8.80▼ | 8.91▼ | 8.87▼ | 9.20▼ | 10.15▼ |
| MA20 | 8.87▼ | 8.86▼ | 8.93▼ | 9.51▼ | 9.98▼ |
| MA50 | 8.85▼ | 9.04▼ | 9.13▼ | 10.43▼ | 8.04▲ |
| MA100 | 8.88▼ | 9.24▼ | 9.41▼ | 9.91▼ | 6.93▲ |
| MA200 | 9.05▼ | 9.49▼ | 9.98▼ | 8.46▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.013▼ | 0.002▲ | 0.006▲ | -0.039▼ | -0.350▼ |
| RSI | 43.122▼ | 43.422▼ | 41.765▼ | 29.967▼ | 46.995▼ |
| STOCH | 31.057 | 43.519 | 48.739 | 15.892▼ | 14.505▼ |
| WILL %R | -59.524 | -76.389▼ | -75.200▼ | -85.897▼ | -92.457▼ |
| CCI | -39.316 | -76.915 | -66.667 | -127.655▼ | -121.072▼ |
| ▼ RSI | $ELTX RSI(14) Crossed Below 30 | Set Alert |
|
Monday, November 03, 2025 06:10 AM
Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced ...
|
|
Monday, October 27, 2025 05:17 AM
ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a ...
|
|
Tuesday, September 30, 2025 09:05 PM
) has been revised to $15.81 / share. This is an increase of 24.00% from the prior estimate of $12.75 dated September 10, 2025. The price target is an average of many targets provided by analysts. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 8.93 | 9.075 | 8.69 | 8.82 | 82,583 |
| 07/11/25 | 9.19 | 9.45 | 8.60 | 8.87 | 146,200 |
| 06/11/25 | 9.15 | 9.21 | 8.89 | 9.07 | 95,900 |
| 05/11/25 | 9.19 | 9.468 | 9.02 | 9.13 | 75,400 |
| 04/11/25 | 9.27 | 9.60 | 9.07 | 9.15 | 147,200 |
| 03/11/25 | 9.48 | 9.50 | 9.00 | 9.25 | 175,500 |
| 31/10/25 | 9.29 | 9.41 | 9.165 | 9.29 | 80,900 |
| 30/10/25 | 9.38 | 9.65 | 9.14 | 9.25 | 124,791 |
| 29/10/25 | 9.64 | 9.81 | 9.35 | 9.40 | 81,800 |
| 28/10/25 | 9.98 | 10.16 | 9.61 | 9.74 | 77,300 |
|
|
||||
|
|
||||
|
|